Company Data
Outlook Therapeutics Inc.
Ticker
OTLK
Current Price
$0.73 -1.35%
Market Cap
$88.2M
Price Target
Refer to Report
Volume
31.3M
52wk Range
$0.1611 - $3.39
Overview
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.